Learning objectives
After watching this webinar, participants will be able to:
Needs assessment and expected educational outcome
To Increase awareness about the importance of cardiovascular risk assessment and optimisation of therapeutic management in patients with T2DM and CKD.
This programme is supported by Bayer AG in the form of an unrestricted financial support. The scientific programme has not been influenced in any way by its sponsor.
Main topic
This webinar is designed for cardiologists, nurses and allied professionals having an interest on the topic. During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
An application has been made to the EACCME® for CME accreditation of this event.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).